PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 23 September 2017 |
| Author/s |
author: Keyvan Rezai Jihane Pakradouni Magali Provansal Renaud Sabatier Jean-Marie Boher |
| Publication date | September 23, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |